Better Data with Bigger Impact

Delivering a 360° IO Community​ to Network and Form Collaborations
Delivering a 360° IO Community​ to Network and Form Collaborations
Build faster and more impactful collaborations with researchers, clinicians, biopharma leaders, investors and policymakers to advance cancer treatments
The Latest Data Driving Broader Impact
The Latest Data Driving Broader Impact
Hear directly from KOLs on the latest data to help advance and improve outcomes for more patients across a wider range of cancers
360° Future-Focused Agenda
360° Future-Focused Agenda
Stay ahead of the curve through 100+ multi-dimensional talks covering preclinical research, translational science, clinical development, operational strategies, cell therapy and business advancements
10+ Hours of Networking Opportunities
10+ Hours of Networking Opportunities
Meet with key stakeholders in biopharma, academia, investors and regulatory through 1:1 meetings and scheduled functions​​​​​​​
io360_keynote

2027 Early Keynotes

Clinical Promise of In Vivo CAR-T

John Pagel, MD, PhD, SVP, Clinical Development, Global Head Medical Oncology, Hematology, Eli Lilly & Co 
 


Transforming Cell Therapy In Vivo

Laurence Zitvogel, MD, PhD, Scientific Director, Gustave Roussy Cancer Center 

2027 Key Topics

Biomarkers & Imaging

Business & Investing Aspects

Discovery / Preclinical Science

Translational Science

Cell Therapy

ADCs & IO

T-Cell Engagers

Cancer Vaccines

Multispecific Antibodies

Precision Immunotherapy

IO Combinations

Novel Targets

Networking and Business Opportunities

Partnering/One-on-One Meetings

  • ​​​​​​​ Dedicated partnering tables to connect with fellow industry professionals, investors and KOLs
  • Partnering tool to schedule partnering meetings
  • Meeting times occur throughout all breaks, lunches and receptions
  • Set up multiple meetings per day
  • Search attendee profiles
  • Send private message to attendees
  • Dedicated partnering help desk

Scheduled Networking

IO360° networking opportunities take place throughout the entire event including:

  • Scheduled morning and afternoon breaks
  • Lunches
  • Reception
  • Access to the Exhibit hall




     
600+
Attendees
125+
Speakers
100+
Talks Over 3 Days
10+
Hours of Networking

Who Attends

AbbVie

Abingworth

Amgen

Astellas Pharma

AstraZeneca

Avidity Partners

Bayer Oncology

BioNTech

BMS

Boehringer Ingelheim

City of Hope

Daichii-Sankyo

Fred Hutchinson Cancer Center

Invus Group

Janssen

Kite Pharma

Memorial Sloan Kettering Cancer Center

Merck

Moderna

Morgan Stanley

Mount Sinai

MPM BioImpact

NCI

Novartis

OrbiMed

RA Capital

Regeneron

Stanford University

Stifel

Takeda

And More!